These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36579116)

  • 21. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic AL Amyloidosis without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab.
    Rybinski B; Kocoglu M
    Am J Case Rep; 2021 Aug; 22():e933241. PubMed ID: 34421115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: A case report.
    Chen W; Ren G; Zuo K; Huang X
    Medicine (Baltimore); 2018 Dec; 97(50):e13589. PubMed ID: 30558027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of AL amyloidosis in 2020.
    Palladini G; Milani P; Merlini G
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):363-371. PubMed ID: 33275753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and Treatment of AL Amyloidosis.
    Palladini G; Milani P
    Drugs; 2023 Feb; 83(3):203-216. PubMed ID: 36652193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis].
    Adam Z; Pour L; Krejcí M; Zahradová L; Krivanová A; Mardová J; Kovárová L; Stepánková S; Moulis M; Kren L; Veselý K; Svobodová I; Germáková Z; Nedbálková M; Mayer J; Hájek R
    Vnitr Lek; 2010 Mar; 56(3):190-209. PubMed ID: 20394205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleural amyloidosis with recurrent pleural effusion and pulmonary embolism: A case report.
    Dai Y; Liu C; Chen J; Zeng Q; Duan C
    Medicine (Baltimore); 2019 Jan; 98(3):e14151. PubMed ID: 30653153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience.
    Roccatello D; Fenoglio R; Naretto C; Baldovino S; Sciascia S; Ferro M; Rossi D
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33050272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis.
    Palladini G; Milani P; Malavasi F; Merlini G
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
    Cohen OC; Brodermann MH; Blakeney IJ; Mahmood S; Sachchithanantham S; Ravichandran S; Law S; Lachmann HJ; Whelan CJ; Popat R; Rabin N; Yong K; Kyriakou C; Shah R; Cheesman S; Worthington S; Hawkins P; Gillmore JD; Wechalekar AD
    Amyloid; 2020 Sep; 27(3):200-205. PubMed ID: 32408823
    [No Abstract]   [Full Text] [Related]  

  • 31. First-line daratumumab shows high efficacy and tolerability even in advanced AL amyloidosis: the real-world experience.
    Jeryczynski G; Antlanger M; Duca F; Binder-Rodriguez C; Reiter T; Simonitsch-Klupp I; Bonderman D; Kain R; Krauth MT; Agis H
    ESMO Open; 2021 Apr; 6(2):100065. PubMed ID: 33667762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed and Relapsed Amyloid Light Chain Amyloidosis: A Single-Center Experience.
    Jimenez-Zepeda VH; Duggan P; Neri P; Bahlis NJ
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e79-84. PubMed ID: 27101985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Light Chain (AL) Cardiac Amyloidosis: A Diagnostic Dilemma.
    Abdelazeem B; Manasrah N; Yousaf A; Gjeka R; Kunadi A
    Cureus; 2021 Nov; 13(11):e19278. PubMed ID: 34881130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment strategy for immunoglobulin light chain amyloidosis].
    Fuchida SI
    Rinsho Ketsueki; 2021; 62(8):1160-1166. PubMed ID: 34497203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful management of refractory pleural effusion due to systemic immunoglobulin light chain amyloidosis by vincristine adriamycin dexamethasone chemotherapy: a case report.
    Araoka T; Takeoka H; Nishioka K; Ikeda M; Kondo M; Hoshina A; Kishi S; Araki M; Mimura R; Murakami T; Mima A; Nagai K; Abe H; Doi T
    J Med Case Rep; 2010 Oct; 4():322. PubMed ID: 20955545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network).
    Sammartano V; Antonioli E; Buda G; Ciofini S; Candi V; Pengue L; Del Giudice ML; Attucci I; Bacchiarri F; Occhini U; Pirrotta MT; Perfetto F; Bocchia M; Gozzetti A
    J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the treatment effect of daratumumab by serial measurements of cardiac biomarkers and imaging parameters in light-chain cardiac amyloidosis.
    Tokai T; Takashio S; Kawano Y; Kidoh M; Oda S; Matsuoka M; Tsujita K
    J Cardiol Cases; 2022 Oct; 26(4):301-304. PubMed ID: 36187319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Successful treatment of myelomatous pleural effusion with daratumumab administration before autologous peripheral stem cell transplantation].
    Wada A; Yasumura S; Kajikawa S; Murakami J; Sato T
    Rinsho Ketsueki; 2020; 61(8):879-884. PubMed ID: 32908050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study.
    Kikukawa Y; Yuki H; Hirata S; Ide K; Nakata H; Miyakawa T; Matsuno N; Nosaka K; Yonemura Y; Kawaguchi T; Hata H; Mitsuya H; Okuno Y
    Int J Hematol; 2015 Feb; 101(2):133-9. PubMed ID: 25430082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis.
    Hassan H; Anwer F; Javaid A; Hashmi H
    Crit Rev Oncol Hematol; 2021 Sep; 165():103435. PubMed ID: 34343658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.